Tech Company Financing Transactions
Congenica Funding Round
On 5/1/2017, Congenica received Series B financing from BGI Genomics, Future Planet Capital and Healthlink Capital.
Transaction Overview
Company Name
Announced On
5/1/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
This additional investment enhances our ability and commitment to deploy our software platform to international markets. Particularly China, where we have established a scalable partnering model to transform the clinical genetic testing market.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Wellcome Genome Campus
Cambridge, CB10 1DR
UK
Cambridge, CB10 1DR
UK
Phone
Website
Email Address
Overview
Congenica is a global company founded on pioneering research from the Sanger Institute based at the Wellcome Genome Campus in Cambridge. NHS clinicians and regional genetic testing laboratories.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Andrew Richards
Chief Executive Officer
David Atkins
Chief Medical Officer
Philip Beales
Chief Scientific Officer
Matthew Hurles
Chief Scientific Officer
Nick Lench
VP - Product Management
Alistair Johnson
Browse more venture capital transactions:
Prev: 5/1/2017: Tribe Insurance venture capital transaction
Next: 5/1/2017: Work Today venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs